Literature DB >> 30687534

Obstructive sleep apnoea and cardiovascular comorbidity-growing evidence of independent association but recent doubts about benefits from therapy.

Walter T McNicholas1,2.   

Abstract

Entities:  

Year:  2018        PMID： 30687534      PMCID： PMC6321891          DOI： 10.21037/jtd.2018.10.118

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  14 in total

1.  Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome.

Authors:  Liam S Doherty; John L Kiely; Valerie Swan; Walter T McNicholas
Journal:  Chest       Date:  2005-06       Impact factor: 9.410

2.  Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial.

Authors:  Justin C T Pepperell; Sharon Ramdassingh-Dow; Nicky Crosthwaite; Rebecca Mullins; Crispin Jenkinson; John R Stradling; Robert J O Davies
Journal:  Lancet       Date:  2002-01-19       Impact factor: 79.321

3.  Effect of Positive Airway Pressure on Cardiovascular Outcomes in Coronary Artery Disease Patients with Nonsleepy Obstructive Sleep Apnea. The RICCADSA Randomized Controlled Trial.

Authors:  Yüksel Peker; Helena Glantz; Christine Eulenburg; Karl Wegscheider; Johan Herlitz; Erik Thunström
Journal:  Am J Respir Crit Care Med       Date:  2016-09-01       Impact factor: 21.405

Review 4.  Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnoea syndrome?

Authors:  S Ryan; C T Taylor; W T McNicholas
Journal:  Thorax       Date:  2009-07       Impact factor: 9.139

5.  Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study.

Authors:  R Heinzer; S Vat; P Marques-Vidal; H Marti-Soler; D Andries; N Tobback; V Mooser; M Preisig; A Malhotra; G Waeber; P Vollenweider; M Tafti; J Haba-Rubio
Journal:  Lancet Respir Med       Date:  2015-02-12       Impact factor: 30.700

6.  Obstructive sleep apnea and diurnal nondipping hemodynamic indices in patients at increased cardiovascular risk.

Authors:  Fadi Seif; Sanjay R Patel; Harneet K Walia; Michael Rueschman; Deepak L Bhatt; Roger S Blumenthal; Stuart F Quan; Daniel J Gottlieb; Eldrin F Lewis; Susheel P Patil; Naresh M Punjabi; Denise C Babineau; Susan Redline; Reena Mehra
Journal:  J Hypertens       Date:  2014-02       Impact factor: 4.844

Review 7.  Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities.

Authors:  W T McNicholas; M R Bonsigore; M R Bonsignore
Journal:  Eur Respir J       Date:  2007-01       Impact factor: 16.671

8.  Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study.

Authors:  Jose M Marin; Santiago J Carrizo; Eugenio Vicente; Alvar G N Agusti
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

9.  Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: randomised controlled trial.

Authors:  Joaquín Durán-Cantolla; Felipe Aizpuru; Jose María Montserrat; Eugeni Ballester; Joaquín Terán-Santos; Jose Ignacio Aguirregomoscorta; Mónica Gonzalez; Patricia Lloberes; Juan Fernando Masa; Mónica De La Peña; Santiago Carrizo; Mercedes Mayos; Ferrán Barbé
Journal:  BMJ       Date:  2010-11-24

10.  Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea.

Authors:  Heinrich F Becker; Andreas Jerrentrup; Thomas Ploch; Ludger Grote; Thomas Penzel; Colin E Sullivan; J Hermann Peter
Journal:  Circulation       Date:  2003-01-07       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.